Wendi Qu

Articles by Wendi Qu

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

24 Patient Preferences for CDK4/6 Inhibitor Treatments in HR+/HER2– Early Breast Cancer: A Discrete Choice Survey Study

ByErica L. Mayer, MD, MPH,Mary Lou Smith,Annie Guérin,Dominick Latrémouille-Viau,Nisha C. Hazra,Yan Meng,Wendi Qu,Remi Bellefleur,Vaidyanathan Ganapathy,Liz Santarsiero,Robert Morlock,Maryam Lustberg

August 2nd 2024

Latest Updated Articles

Trending on CancerNetwork

Closing the HCC Surveillance Gap in MASLD Without Cirrhosis

Changing Mindsets and Removing Guilt Surrounding Lung Cancer Diagnoses

Rethinking Surveillance and Multidisciplinary Care in MASLD-Related HCC

Closing the Gap Between Tumor Board Recommendations and Liver Cancer Care

Weighing HCC Surveillance for Patients With MASLD and F3 Fibrosis